Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs

Gary G. Liversidge, Kenneth C. Cundy
In: International Journal of Pharmaceutics · 1995 · vol. 125(1) , pp. 91–97 · doi:10.1016/0378-5173(95)00122-y · W2070825233
article OA: closed CC0 ⤵ 21 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

This study investigated the absolute oral bioavailability of nanocrystalline danazol compared to a microcrystalline suspension in beagle dogs to assess the impact of particle size reduction.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (10)

Cited by (19)

Source provenance

openalex
last seen: 2026-05-10T11:21:09.667777+00:00
unpaywall
last seen: 2026-10-03T06:31:36.481334+00:00
License: CC0 · commercial use OK